BridgeMD
New treatment option for Obesity
Official title Weight Management in Obese Cancer Patients During Curative Active Treatment
ClinicalTrials.gov ID: NCT07058207
What this study is testing
- What it's testing
- This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain. The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with...
- Expected oncological treatment time ≥ 3 months.
- BMI ≥ 30 kg/m²
- Resident in the Barcelona area up to the completion of cancer treatment.
- ECOG Perfomance Status (PS) 0-1
You likely can't join if
- Patients with melanoma and brain tumours.
- Surgery as the only treatment.
- Tumour localizations with high risk of malnutrition (such as head and neck, upper gastrointestinal tract, or pancreatic cancer):
- Pregnancy or breastfeeding
- Another active malignancy
- Current health or medical condition that affects weight status, e.g., untreated hyper- or hypothyroidism,etc
See the full eligibility criteria
- Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with curative intend.
- Expected oncological treatment time ≥ 3 months.
- BMI ≥ 30 kg/m²
- Resident in the Barcelona area up to the completion of cancer treatment.
- ECOG Perfomance Status (PS) 0-1
- Availability of internet access.
- Patients with melanoma and brain tumours.
- Surgery as the only treatment.
- Tumour localizations with high risk of malnutrition (such as head and neck, upper gastrointestinal tract, or pancreatic cancer):
- Pregnancy or breastfeeding
- Another active malignancy
- Current health or medical condition that affects weight status, e.g., untreated hyper- or hypothyroidism,etc
- Pre-existing medical condition that precludes adherence to unsupervised exercise, e.g., severe orthopedic conditions, scheduled for a hip or knee replacement, bone metastases, paralysis, dementia, untreated stage 3...
- Unable to read or understand Spanish or Catalan
- Enrolled in a weight loss program
- Active suicidal ideation, anorexia, bulimia, binge eating disorder, current substance abuse or dependence (besides nicotine dependence)
- Use of pacemaker or another electrical implanted device
- History of bariatric (or LapBand) surgery, or considering or currently on a wait-list for bariatric or LapBand surgery
- Patients with any concurrent medical or psychological condition that, in the investigator's opinion, would jeopardize the safety of the patient or compliance with the protocol.
The study team makes the final eligibility decision.
Where it's taking place
- L'Hospitalet de Llobregat, Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include L'Hospitalet de Llobregat, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.